Description

Setegys (terazosin) tablets 5 mg. №30

Ingredients

Active ingredient: Terazosin hydrochloride 5 mg.
Other ingredients: Lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, colloidal silicon dioxide, and magnesium stearate.

Dosage

Recommended dosage: The usual starting dose is 1 mg at bedtime, which can be gradually increased under medical supervision. The maximum recommended dose is 10 mg once daily.

Indications

Setegys (terazosin) tablets are indicated for the treatment of hypertension and benign prostatic hyperplasia (BPH).

Contraindications

Setegys tablets are contraindicated in patients with a known hypersensitivity to terazosin or any of the tablet’s components. It should not be used in patients with a history of orthostatic hypotension.

Directions

Take Setegys tablets orally, once daily at bedtime. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.

Scientific Evidence

Terazosin, the active ingredient in Setegys tablets, is an alpha-1 adrenergic blocker that works by relaxing blood vessels and improving blood flow. Studies have shown that terazosin is effective in lowering blood pressure and improving symptoms of BPH. Research published in the Journal of Urology demonstrated the efficacy of terazosin in reducing urinary symptoms associated with BPH.

Additional Information

It is important to monitor blood pressure regularly while taking Setegys tablets, especially at the beginning of treatment and after dose adjustments. Common side effects may include dizziness, headache, and fatigue. If you experience prolonged or painful erections, seek medical attention immediately.

Pharmacological Effects: Terazosin works by blocking alpha-1 receptors in the body, leading to vasodilation and decreased peripheral vascular resistance. This action results in lower blood pressure and improved urinary flow in patients with BPH.

Clinical Trials: Clinical trials have shown that terazosin is effective in reducing both systolic and diastolic blood pressure in hypertensive patients. A study published in the American Journal of Medicine found that terazosin was well-tolerated and significantly reduced blood pressure compared to placebo.